These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20084527)

  • 41. Advanced glycation end products promote ChREBP expression and cell proliferation in liver cancer cells by increasing reactive oxygen species.
    Chen H; Li Y; Zhu Y; Wu L; Meng J; Lin N; Yang D; Li M; Ding W; Tong X; Su Q
    Medicine (Baltimore); 2017 Aug; 96(33):e7456. PubMed ID: 28816938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
    Yuan Y; Sun H; Sun Z
    Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glyceraldehyde-derived advanced glycation end products (AGEs). A novel biomarker of postprandial hyperglycaemia in diabetic rats.
    Kitahara Y; Takeuchi M; Miura K; Mine T; Matsui T; Yamagishi S
    Clin Exp Med; 2008 Sep; 8(3):175-7. PubMed ID: 18791692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caffeic Acid Inhibits the Formation of Advanced Glycation End Products (AGEs) and Mitigates the AGEs-Induced Oxidative Stress and Inflammation Reaction in Human Umbilical Vein Endothelial Cells (HUVECs).
    Cao X; Xia Y; Zeng M; Wang W; He Y; Liu J
    Chem Biodivers; 2019 Oct; 16(10):e1900174. PubMed ID: 31419039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Receptor for advanced glycation end products (RAGE)-mediated cytotoxicity of 3-hydroxypyridinium derivatives.
    Murakami Y; Fujino T; Hasegawa T; Kurachi R; Miura A; Daikoh T; Usui T; Hayase F; Watanabe H
    Biosci Biotechnol Biochem; 2018 Feb; 82(2):312-319. PubMed ID: 29316860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products.
    Watanabe M; Kawai Y; Kitayama M; Akao H; Motoyama A; Wakasa M; Saito R; Aoki H; Fujibayashi K; Tsuchiya T; Nakanishi H; Saito K; Takeuchi M; Kajinami K
    J Cardiol; 2017 Apr; 69(4):625-631. PubMed ID: 27470137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?
    Schwedler S; Schinzel R; Vaith P; Wanner C
    Kidney Int Suppl; 2001 Feb; 78():S32-6. PubMed ID: 11168979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plantamajoside Inhibits UVB and Advanced Glycation End Products-Induced MMP-1 Expression by Suppressing the MAPK and NF-κB Pathways in HaCaT Cells.
    Han AR; Nam MH; Lee KW
    Photochem Photobiol; 2016 Sep; 92(5):708-19. PubMed ID: 27346084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
    Jeyabal PV; Kumar R; Gangula PR; Micci MA; Pasricha PJ
    Neurogastroenterol Motil; 2008 Mar; 20(3):253-61. PubMed ID: 17971026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease.
    Takeuchi M; Yamagishi S
    J Alzheimers Dis; 2009; 16(4):845-58. PubMed ID: 19387117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.
    Takeuchi M; Takino J; Sakasai-Sakai A; Takata T; Ueda T; Tsutsumi M; Hyogo H; Yamagishi S
    World J Hepatol; 2014 Dec; 6(12):880-93. PubMed ID: 25544875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis.
    Hyogo H; Yamagishi S; Iwamoto K; Arihiro K; Takeuchi M; Sato T; Ochi H; Nonaka M; Nabeshima Y; Inoue M; Ishitobi T; Chayama K; Tazuma S
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1112-9. PubMed ID: 17559366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan.
    Takeuchi M; Takino J; Furuno S; Shirai H; Kawakami M; Muramatsu M; Kobayashi Y; Yamagishi S
    PLoS One; 2015; 10(3):e0118652. PubMed ID: 25730321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stress responses of human retinal pigment epithelial cells to glyoxal.
    Roehlecke C; Valtink M; Frenzel A; Goetze D; Knels L; Morawietz H; Funk RH
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2361-2372. PubMed ID: 27520463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells.
    Franke S; Sommer M; Rüster C; Bondeva T; Marticke J; Hofmann G; Hein G; Wolf G
    Arthritis Res Ther; 2009; 11(5):R136. PubMed ID: 19735566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytotoxicity and oxidative stress induced by the glyceraldehyde-related Maillard reaction products for HL-60 cells.
    Usui T; Shizuuchi S; Watanabe H; Hayase F
    Biosci Biotechnol Biochem; 2004 Feb; 68(2):333-40. PubMed ID: 14981296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats.
    Chen L; Wang T; Wang X; Sun BB; Li JQ; Liu DS; Zhang SF; Liu L; Xu D; Chen YJ; Wen FQ
    Respir Res; 2009 Jun; 10(1):55. PubMed ID: 19552800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis.
    Li JJ; Dickson D; Hof PR; Vlassara H
    Mol Med; 1998 Jan; 4(1):46-60. PubMed ID: 9513189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.